PTGIR and colitis: Overall, these data indicate that the antifibrotic effect of the PTGIR agonist in both acute and chronic colitis murine models is correlated with reduced YAP stromal expression, which suggests that PGI2-PTGIR activation may prevent intestinal fibrosis by downregulating YAP.